Lifeward Ltd. announced its financial results for the first quarter of 2025 on May 15, 2025, reporting revenue of $5.0 million, a decrease of $0.3 million compared to $5.3 million in Q1 2024. The prior year's quarter included $0.5 million in catch-up revenue from 2023 Medicare rentals.
Revenue from AlterG products and services increased by 17% to $3.3 million, driven by greater international demand. Gross margin improved to 42.2% on both GAAP and non-GAAP adjusted bases, up from 26.4% and 33.7% respectively in Q1 2024, attributed to a favorable ReWalk payor mix and AlterG volume.
Operating expenses decreased to $7.0 million (GAAP) and $6.8 million (non-GAAP adjusted) due to savings from the Fremont facility closure and completion of R&D programs. The company reported a net loss of $4.8 million, or $0.46 per share. As of March 31, 2025, cash and cash equivalents stood at $5.7 million, with $5.49 million used in operations during the quarter. Lifeward reaffirmed its full-year 2025 revenue guidance of $28 million to $30 million.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.